-
1صورة
المؤلفون: D. J Ouyang (11335068), Q. T Chen (11335071), M. Anwar (10404872), N. Xie (7698083), Q. C. Ouyang (11335074), P. Z. Fan (11335077), L. Y. Qian (11335080), G. N. Chen (11335083), E. X. Zhou (11335086), L. Guo (4453888), X. W. Gu (11335089), B. N. Ding (11335092), X. H. Yang (11335095), L. P. Liu (11335098), C. Deng (6652631), Z. Xiao (3604901), J. Li (51350), Y. Q. Wang (4918831), S. Zeng (11335101), Shouman Wang (3842485), Wenjun Yi (8888957)
مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, pyrotinib, lapatinib-treated, lapatinib-naive, HER2 breast cancer, metastases
-
2صورة
المؤلفون: D. J Ouyang, Q. T Chen, M. Anwar, N. Xie, Q. C. Ouyang, P. Z. Fan, L. Y. Qian, G. N. Chen, E. X. Zhou, L. Guo, X. W. Gu, B. N. Ding, X. H. Yang, L. P. Liu, C. Deng, Z. Xiao, J. Li, Y. Q. Wang, S. Zeng, Shouman Wang, Wenjun Yi
مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, pyrotinib, lapatinib-treated, lapatinib-naive, HER2 breast cancer, metastases
الإتاحة: https://doi.org/10.3389/fphar.2021.682568.s001Test
https://figshare.com/articles/figure/Image1_The_Efficacy_of_Pyrotinib_as_a_Third-_or_Higher-Line_Treatment_in_HER2-Positive_Metastatic_Breast_Cancer_Patients_Exposed_to_Lapatinib_Compared_to_Lapatinib-Naive_Patients_A_Real-World_Study_pdf/16443816Test
